Nogo-A is a reliable oligodendroglial marker in adult human and mouse CNS and in demyelinated lesions

被引:91
作者
Kuhlmann, Tanja
Remington, Leah
Maruschak, Brigitte
Owens, Trevor
Brueck, Wolfgang
机构
[1] Univ Gottingen, Dept Neuropathol, D-37075 Gottingen, Germany
[2] McGill Univ, Neuroimmunol Unit, Montreal Neurol Inst, Montreal, PQ, Canada
[3] Univ So Denmark, Ctr Med Biotechnol, Odense, Denmark
[4] Univ Gottingen, Inst Multiple Sklerose Forsch, Bereich Humanmed, D-3400 Gottingen, Germany
[5] Gemeinnutzige Hertie Stiftung, Gottingen, Germany
关键词
cuprizone-induced demyelination; experimental autoimmune-mediated encephalomyelitis; multiple sclerosis; Nogo-A; oligodendrocytes;
D O I
10.1097/01.jnen.0000248559.83573.71
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The unambiguous identification of oligodendrocytes in tissue sections, especially in myelinated tracts, is often difficult. Most of the antibodies used to identify oligodendrocytes label the myelin sheath as well. Originally described as an inhibitor of axonal outgrowth, Nogo-A is known to be strongly expressed in mature oligodendrocytes in vivo. In the present investigation we analyzed the expression patterns of Nogo-A in adult mouse and human CNS as well as in demyelinating animal models and multiple sclerosis lesions. Nogo-A expression was compared with that of other frequently used oligodendroglial markers such as CC1, CNP, and in situ hybridization for proteolipid protein mRNA. Nogo-A strongly and reliably labeled oligodendrocytes in the adult CNS as well as in demyelinating lesions and thus represents a valuable tool for the identification of oligodendrocytes in human and mouse CNS tissue.
引用
收藏
页码:238 / 246
页数:9
相关论文
共 33 条
[1]   A new role for Nogo as a regulator of vascular remodeling [J].
Acevedo, L ;
Yu, J ;
Erdjument-Bromage, H ;
Miao, RQ ;
Kim, JE ;
Fulton, D ;
Tempst, P ;
Strittmatter, SM ;
Sessa, WC .
NATURE MEDICINE, 2004, 10 (04) :382-388
[2]  
Bhat RV, 1996, GLIA, V17, P169
[3]   RECOVERY FROM SPINAL-CORD INJURY MEDIATED BY ANTIBODIES TO NEURITE GROWTH-INHIBITORS [J].
BREGMAN, BS ;
KUNKELBAGDEN, E ;
SCHNELL, L ;
DAI, HN ;
GAO, D ;
SCHWAB, ME .
NATURE, 1995, 378 (6556) :498-501
[4]  
BREITSCHOPF H, 1992, ACTA NEUROPATHOL, V84, P581
[5]   Expression pattern of NOGO-A protein in the human nervous system [J].
Buss, A ;
Sellhaus, B ;
Wolmsley, A ;
Noth, J ;
Schwab, ME ;
Brook, GA .
ACTA NEUROPATHOLOGICA, 2005, 110 (02) :113-119
[6]   IDENTIFICATION OF 2 LYSOSOMAL MEMBRANE-GLYCOPROTEINS [J].
CHEN, JW ;
MURPHY, TL ;
WILLINGHAM, MC ;
PASTAN, I ;
AUGUST, JT .
JOURNAL OF CELL BIOLOGY, 1985, 101 (01) :85-95
[7]   Nogo-A is a myelin-associated neurite outgrowth inhibitor and an antigen for monoclonal antibody IN-1 [J].
Chen, MS ;
Huber, AB ;
van der Haar, ME ;
Frank, M ;
Schnell, L ;
Spillmann, AA ;
Christ, F ;
Schwab, ME .
NATURE, 2000, 403 (6768) :434-439
[8]   The neurotrophin receptor p75NTR:: novel functions and implications for diseases of the nervous system [J].
Dechant, G ;
Barde, YA .
NATURE NEUROSCIENCE, 2002, 5 (11) :1131-1136
[9]   Immunity to the extracellular domain of Nogo-A modulates experimental autoimmune encephalomyelitis [J].
Fontoura, P ;
Ho, PP ;
DeVoss, J ;
Zheng, BH ;
Lee, BJ ;
Kidd, BA ;
Garren, H ;
Sobel, RA ;
Robinson, WH ;
Tessier-Lavigne, M ;
Steinman, L .
JOURNAL OF IMMUNOLOGY, 2004, 173 (11) :6981-6992
[10]   Identification of a receptor mediating Nogo-66 inhibition of axonal regeneration [J].
Fournier, AE ;
GrandPre, T ;
Strittmatter, SM .
NATURE, 2001, 409 (6818) :341-346